Somewhat Favorable News Coverage Somewhat Unlikely to Affect Spectranetics Corp (NASDAQ:SPNC) Stock Price

News headlines about Spectranetics Corp (NASDAQ:SPNC) have trended somewhat positive on Saturday, Accern reports. The research firm rates the sentiment of media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Spectranetics Corp earned a media sentiment score of 0.23 on Accern’s scale. Accern also assigned media headlines about the medical equipment provider an impact score of 44.8356137603812 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Shares of Spectranetics Corp (NASDAQ SPNC) opened at 38.45 on Friday. The company’s 50-day moving average price is $37.28 and its 200-day moving average price is $30.10. Spectranetics Corp has a 52-week low of $19.80 and a 52-week high of $38.55.

Spectranetics Corp (NASDAQ:SPNC) last issued its quarterly earnings data on Thursday, August 3rd. The medical equipment provider reported ($0.56) earnings per share for the quarter, missing the consensus estimate of ($0.27) by $0.29. The business had revenue of $74.71 million during the quarter, compared to the consensus estimate of $73.82 million. Spectranetics Corp had a negative return on equity of 194.18% and a negative net margin of 32.93%. The business’s revenue for the quarter was up 10.3% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.35) EPS. Analysts forecast that Spectranetics Corp will post ($1.16) EPS for the current year.

A number of equities analysts have recently issued reports on SPNC shares. Needham & Company LLC reissued a “buy” rating and issued a $38.50 target price on shares of Spectranetics Corp in a report on Wednesday, June 28th. BidaskClub cut Spectranetics Corp from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 10th. Northland Securities reissued a “buy” rating and issued a $32.00 target price on shares of Spectranetics Corp in a report on Friday, April 28th. Royal Bank Of Canada reissued a “hold” rating and issued a $27.00 target price on shares of Spectranetics Corp in a report on Friday, April 28th. Finally, Zacks Investment Research raised Spectranetics Corp from a “sell” rating to a “hold” rating in a report on Thursday, April 27th. Eleven investment analysts have rated the stock with a hold rating and one has given a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $35.36.

WARNING: “Somewhat Favorable News Coverage Somewhat Unlikely to Affect Spectranetics Corp (NASDAQ:SPNC) Stock Price” was posted by Community Financial News and is owned by of Community Financial News. If you are reading this piece on another site, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this piece can be viewed at https://www.com-unik.info/2017/08/19/the-spectranetics-corporation-nasdaqspnc-earning-somewhat-positive-news-coverage-report-shows-updated-updated.html.

Spectranetics Corp Company Profile

The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company’s products are used to cross, prepare and treat arterial blockages in the heart and legs and to manage pacemaker and defibrillator cardiac leads.

Insider Buying and Selling by Quarter for Spectranetics Corp (NASDAQ:SPNC)

What are top analysts saying about Spectranetics Corp? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Spectranetics Corp and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit